SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
ONC reported Q3 2026 results. The stock moved +2.5% on the print.
ONCearnings

Earnings reactions, page 7

BeOne Medicines Ltd. (ONC) Q3 FY2026 earnings

November 5, 2026 · SharpeIQ Research Desk

Reported results

  • Total revenue of $1.889815 billion on a GAAP basis for the third quarter of 2026.
  • BRUKINSA global revenues of $1.4 billion for the third quarter of 2026.
  • GAAP diluted Earnings per ADS of $3.28 for the third quarter of 2026.
  • Non-GAAP diluted Earnings per ADS of $4.59 for the third quarter of 2026.
  • GAAP income from operations of $418.675 million for the third quarter of 2026.
  • Adjusted income from operations of $612.226 million for the third quarter of 2026.

Guidance

  • Full year 2026 total revenue guidance of $6.9 billion to $7.0 billion.
  • Full year 2026 GAAP operating income guidance of $1.2 billion to $1.3 billion.
  • Full year 2026 non-GAAP operating income guidance of $1.9 billion to $2.0 billion.
  • Full year 2026 GAAP operating expenses guidance of $4.9 billion to $5.0 billion.
  • Full year 2026 GAAP gross margin percentage guidance in the high-80% range.

Notes

The company reported a non-cash intangible asset impairment charge of $22 million associated with the decision to discontinue promotion of POBEVCY.

Price and volatility reaction

The stock moved +2.5% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -0.8 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release377.782026-11-04
Close after release387.252026-11-05
Realised move+2.5%close to close
30d ATM IV change-0.8 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →